Priska Stahel1, Changting Xiao1, Xenia Davis2, Patrick Tso2, Gary F Lewis1. 1. From the Division of Endocrinology and Metabolism, Department of Medicine and Physiology, Banting & Best Diabetes Centre, University of Toronto, ON, Canada (P.S., C.X., G.F.L.). 2. Department of Pathology and Laboratory Medicine, University of Cincinnati, OH (X.D., P.T.).
Abstract
OBJECTIVE: Dietary triglycerides are partially retained in the intestine within intracellular or extracellular compartments, which can be rapidly mobilized in response to several stimuli, including glucose and GLP-2 (glucagon-like peptide-2). To elucidate the mechanism of intestinal lipid mobilization, this study examined the patterns and time course of lymph flow and triglycerides after glucose and GLP-2 treatment in rats. Approach and Results: Lymph flow, triglyceride concentration, and triglyceride output were assessed in mesenteric lymph duct-cannulated rats in response to an intraduodenal (i.d.) lipid bolus followed 5 hours later by either (1) i.d. saline+intraperitoneal (i.p.) saline (placebo), (2) i.d. glucose plus i.p. saline, (3) i.d. saline+i.p. GLP-2, or (4) i.d. glucose+i.p. GLP-2. GLP-2 and glucose administered alone or in combination stimulated total triglyceride output to a similar extent, but the timing and pattern of stimulation differed markedly. Whereas GLP-2 rapidly increased lymph flow with no effect on lymph triglyceride concentration or triglyceride:apoB48 (apolipoprotein B48) ratio (a surrogate marker of chylomicron size) compared with placebo, glucose transiently decreased lymph flow followed by delayed stimulation of lymph flow and increased lymph triglyceride concentration and triglyceride:apoB48 ratio. CONCLUSIONS: Glucose and GLP-2 robustly enhanced intestinal triglyceride output in rats but with different effects on lymph flow, lymph triglyceride concentration, and chylomicron size. GLP-2 stimulated triglyceride output primarily by enhancing lymph flow with no effect on chylomicron size, whereas glucose mobilized intestinal triglycerides, stimulating secretion of larger chylomicrons. This suggests that these 2 stimuli mobilize intestinal lipid by different mechanisms.
OBJECTIVE: Dietary triglycerides are partially retained in the intestine within intracellular or extracellular compartments, which can be rapidly mobilized in response to several stimuli, including glucose and GLP-2 (glucagon-like peptide-2). To elucidate the mechanism of intestinal lipid mobilization, this study examined the patterns and time course of lymph flow and triglycerides after glucose and GLP-2 treatment in rats. Approach and Results: Lymph flow, triglyceride concentration, and triglyceride output were assessed in mesenteric lymph duct-cannulated rats in response to an intraduodenal (i.d.) lipid bolus followed 5 hours later by either (1) i.d. saline+intraperitoneal (i.p.) saline (placebo), (2) i.d. glucose plus i.p. saline, (3) i.d. saline+i.p. GLP-2, or (4) i.d. glucose+i.p. GLP-2. GLP-2 and glucose administered alone or in combination stimulated total triglyceride output to a similar extent, but the timing and pattern of stimulation differed markedly. Whereas GLP-2 rapidly increased lymph flow with no effect on lymph triglyceride concentration or triglyceride:apoB48 (apolipoprotein B48) ratio (a surrogate marker of chylomicron size) compared with placebo, glucose transiently decreased lymph flow followed by delayed stimulation of lymph flow and increased lymph triglyceride concentration and triglyceride:apoB48 ratio. CONCLUSIONS:Glucose and GLP-2 robustly enhanced intestinal triglyceride output in rats but with different effects on lymph flow, lymph triglyceride concentration, and chylomicron size. GLP-2 stimulated triglyceride output primarily by enhancing lymph flow with no effect on chylomicron size, whereas glucose mobilized intestinal triglycerides, stimulating secretion of larger chylomicrons. This suggests that these 2 stimuli mobilize intestinal lipid by different mechanisms.
Authors: Eleanor M Scott; John P Greenwood; Giovanni Vacca; John B Stoker; Stephen G Gilbey; David A S G Mary Journal: Clin Sci (Lond) Date: 2002-05 Impact factor: 6.124
Authors: Alison B Kohan; Qing Yang; Min Xu; Dana Lee; Patrick Tso Journal: Am J Physiol Gastrointest Liver Physiol Date: 2016-08-11 Impact factor: 4.052
Authors: Nicole J W de Wit; Mark V Boekschoten; Eva-Maria Bachmair; Guido J E J Hooiveld; Philip J de Groot; Isabel Rubio-Aliaga; Hannelore Daniel; Michael Müller Journal: PLoS One Date: 2011-04-25 Impact factor: 3.240
Authors: Changting Xiao; Priska Stahel; Alicia L Carreiro; Yu-Han Hung; Satya Dash; Ian Bookman; Kimberly K Buhman; Gary F Lewis Journal: Cell Mol Gastroenterol Hepatol Date: 2018-10-12
Authors: Kellie A Kroscher; Dane W Fausnacht; Ryan P McMillan; Samer W El-Kadi; Emma H Wall; David M Bravo; Robert P Rhoads Journal: J Anim Sci Date: 2022-08-01 Impact factor: 3.338
Authors: Henry N Ginsberg; Chris J Packard; M John Chapman; Jan Borén; Carlos A Aguilar-Salinas; Maurizio Averna; Brian A Ference; Daniel Gaudet; Robert A Hegele; Sander Kersten; Gary F Lewis; Alice H Lichtenstein; Philippe Moulin; Børge G Nordestgaard; Alan T Remaley; Bart Staels; Erik S G Stroes; Marja-Riitta Taskinen; Lale S Tokgözoğlu; Anne Tybjaerg-Hansen; Jane K Stock; Alberico L Catapano Journal: Eur Heart J Date: 2021-12-14 Impact factor: 29.983